RU2017107235A3 - - Google Patents

Download PDF

Info

Publication number
RU2017107235A3
RU2017107235A3 RU2017107235A RU2017107235A RU2017107235A3 RU 2017107235 A3 RU2017107235 A3 RU 2017107235A3 RU 2017107235 A RU2017107235 A RU 2017107235A RU 2017107235 A RU2017107235 A RU 2017107235A RU 2017107235 A3 RU2017107235 A3 RU 2017107235A3
Authority
RU
Russia
Application number
RU2017107235A
Other languages
Russian (ru)
Other versions
RU2017107235A (ru
RU2692252C3 (ru
RU2692252C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54199901&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2017107235(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of RU2017107235A publication Critical patent/RU2017107235A/ru
Publication of RU2017107235A3 publication Critical patent/RU2017107235A3/ru
Application granted granted Critical
Publication of RU2692252C2 publication Critical patent/RU2692252C2/ru
Publication of RU2692252C3 publication Critical patent/RU2692252C3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
RU2017107235A 2015-08-31 Кристаллические твердые формы 6-карбокси-2-(3,5-дихлорфенил)бензоксазола RU2692252C3 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462047614P 2014-09-08 2014-09-08
US62/047,614 2014-09-08
US201562203953P 2015-08-12 2015-08-12
US62/203,953 2015-08-12
PCT/IB2015/056597 WO2016038500A1 (en) 2014-09-08 2015-08-31 Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole

Publications (4)

Publication Number Publication Date
RU2017107235A RU2017107235A (ru) 2018-10-11
RU2017107235A3 true RU2017107235A3 (enExample) 2018-10-11
RU2692252C2 RU2692252C2 (ru) 2019-06-24
RU2692252C3 RU2692252C3 (ru) 2023-01-13

Family

ID=

Also Published As

Publication number Publication date
CA2903194A1 (en) 2016-03-08
US9770441B1 (en) 2017-09-26
CY1124843T1 (el) 2022-11-25
EP4349406A2 (en) 2024-04-10
TWI644902B (zh) 2018-12-21
HUE065233T2 (hu) 2024-05-28
CN106715405A (zh) 2017-05-24
SI3191461T1 (sl) 2022-01-31
JP2025108584A (ja) 2025-07-23
PL3191461T3 (pl) 2022-02-07
RU2017107235A (ru) 2018-10-11
RS62634B1 (sr) 2021-12-31
HUE056583T2 (hu) 2022-02-28
FI4349406T3 (fi) 2026-02-04
SG11201700958YA (en) 2017-03-30
DK3977993T3 (da) 2024-02-19
JP2023134645A (ja) 2023-09-27
EP4349406B1 (en) 2025-12-03
IL251037B1 (en) 2024-10-01
AU2015313875B2 (en) 2018-03-15
BR112017003421A2 (pt) 2017-11-28
PT4349406T (pt) 2026-02-04
MX2017002954A (es) 2017-06-15
PL4349406T3 (pl) 2026-03-23
JP7357525B2 (ja) 2023-10-06
FI3977993T3 (fi) 2024-03-25
EP3191461A1 (en) 2017-07-19
JP2020055832A (ja) 2020-04-09
TW201613880A (en) 2016-04-16
NZ766084A (en) 2023-12-22
ES2901785T3 (es) 2022-03-23
EP3977993B1 (en) 2024-01-31
KR102004059B1 (ko) 2019-07-25
LT3191461T (lt) 2021-12-10
JP2022024014A (ja) 2022-02-08
HRP20211834T1 (hr) 2022-03-04
EP4349406A3 (en) 2024-05-22
SI4349406T1 (sl) 2026-02-27
EP3977993A1 (en) 2022-04-06
SI3977993T1 (sl) 2024-05-31
NZ729011A (en) 2023-10-27
PT3191461T (pt) 2021-12-27
MX374012B (es) 2020-07-22
WO2016038500A1 (en) 2016-03-17
CN115368313A (zh) 2022-11-22
PT3977993T (pt) 2024-04-01
RU2692252C2 (ru) 2019-06-24
EP3191461B1 (en) 2021-11-03
BR112017003421B1 (pt) 2023-10-10
AU2015313875A1 (en) 2017-03-02
JP2016065042A (ja) 2016-04-28
ES2975633T3 (es) 2024-07-10
PL3977993T3 (pl) 2024-05-06
US20170273953A1 (en) 2017-09-28
DK4349406T3 (da) 2026-02-02
ES3061774T3 (en) 2026-04-07
IL251037A0 (en) 2017-04-30
KR20170040314A (ko) 2017-04-12

Similar Documents

Publication Publication Date Title
BR112016017979A2 (enExample)
BR112016016761A2 (enExample)
BR112016015519A2 (enExample)
BR112016015890A2 (enExample)
BR112016003131A2 (enExample)
BR112016016490A2 (enExample)
BR112016016546A2 (enExample)
BR112016014949A2 (enExample)
BR112016018264A2 (enExample)
BR112016016924A2 (enExample)
BR112016016421A2 (enExample)
BR112016016106A2 (enExample)
BR112016012568A2 (enExample)
BR112016016558A2 (enExample)
BR112016017960A2 (enExample)
BR112016015915A2 (enExample)
BR112016018252A2 (enExample)
BR112016016389A2 (enExample)
BR112016016468A2 (enExample)
BR112016017356A2 (enExample)
BR112016016459A2 (enExample)
BR112016003522A2 (enExample)
BR112016014482A2 (enExample)
BR112016018021A2 (enExample)
BR112016017135A2 (enExample)